Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients

• Status: Terminated
• Trial end date: 2006-03-29
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut de Recherches Internationales Servier

Criteria

Inclusion Criteria:

• Memory complaint

• Acetylcholinesterase inhibitors stopped at least 3 months before selection

Exclusion Criteria:

• Dementia

• Parkinson's disease

• Vascular disorder

• Depression

• Epilepsy